Food News and Research

RSS

Behavioral change programs help lower risk for cardiovascular diseases: Scientific statement

Combining counseling, extended follow-up with a healthcare provider and self-monitoring of diet and exercise is the most effective way to help patients embrace lifestyle changes that can lower their risk for heart and blood vessel (cardiovascular) diseases, according to a scientific statement published in Circulation: Journal of the American Heart Association.

13 Jul 2010

Food portion control is a matter of perception, suggests study

Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, suggests that the key to losing weight could lie in manipulating our beliefs about how filling we think food will be before we eat it, suggesting that portion control is all a matter of perception.

13 Jul 2010

Watson Laboratories files ANDA with FDA for generic Renvela for oral suspension

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market sevelamer carbonate for oral suspension, 0.8g and 2.4g per packet. Watson's sevelamer carbonate for oral suspension product is the generic version of Genzyme's Renvela for Oral Suspension.

13 Jul 2010

Human Genome Sciences, Lonza announce commercial supply agreement for BENLYSTA

Human Genome Sciences, Inc. and Lonza today announced an agreement for the future commercial supply of BENLYSTA® (belimumab), which is currently under regulatory review in the United States and Europe as a potential new treatment for systemic lupus erythematosus (SLE). BENLYSTA is being developed by HGS and GlaxoSmithKline (GSK) under a co-development and commercialization agreement entered into in 2006.

13 Jul 2010

Fresh salsa and guacamole may be important vehicles of foodborne infection, says ORISE researcher

Nearly 1 out of every 25 restaurant-associated foodborne outbreaks with identified food sources between 1998 and 2008 can be traced back to contaminated salsa or guacamole, more than double the rate during the previous decade, according to research released by the Centers for Disease Control and Prevention today at the International Conference on Emerging Infectious Diseases.

13 Jul 2010

Exercise can reverse effects of early-life trauma

Athletes have long known about the natural “high” exercise can induce. Now, for the first time, medical researchers have demonstrated that exercise can reverse the effects in the brain of psychological trauma experienced early in life.

13 Jul 2010

Tart cherry juice could help reduce severity of insomnia in older adults: Study

Drinking tart cherry juice daily could help reduce the severity of insomnia and time spent awake after going to sleep, according to a new study published in the Journal of Medicinal Food.

13 Jul 2010

Portion control all a matter of perception!

The key to losing weight could lie in manipulating our beliefs about how filling we think food will be before we eat it, suggesting that portion control is all a matter of perception.

13 Jul 2010

News outlets examine Haitian rebuilding effort six months after major quake

"Six months to the day since a magnitude-7.0 earthquake leveled 60% of [Port-Au-Prince's] buildings and killed 230,000 people, there are few visible signs of improvement," USA Today reports.

13 Jul 2010

Government report questions double use of CT scans at Illinois, Florida hospitals

Chicago Tribune: Doctors at Illinois hospitals are coming under closer scrutiny after a report questioned the use of "double CT scans," which subjected patients to higher radiation. For some procedures, doctors scanned once using a dye once and once without at a rate higher than in other states. "The hospital launched an investigation, and physicians began to focus on curbing use of the scans.

13 Jul 2010

Efficacy data of Caldolor Injection in treating fever associated with falciparum malaria published

Cumberland Pharmaceuticals Inc. today announced that data supporting the efficacy of Caldolor in treating fever associated with falciparum malaria was published in the July edition of the peer-reviewed American Journal of Tropical Medicine and Hygiene. The study, which is the first to document an antipyretic effect of an injectable non-steroidal anti-inflammatory drug on fever caused by malaria, demonstrated that patients who received intravenous ibuprofen experienced a greater reduction in their temperatures than those who received placebo.

13 Jul 2010

BioSpecifics' partner Auxilium provides update on XIAFLEX

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its strategic partner Auxilium Pharmaceuticals, Inc. has provided an update on XIAFLEX, its injectable collagenase product currently marketed in the U.S. for the treatment of Dupuytren's contracture.

13 Jul 2010

B. Braun Medical announces availability of large volume heparin infusion solutions

B. Braun Medical Inc. announced today the availability of large volume heparin infusion solutions.

From B. Braun Melsungen AG 12 Jul 2010

Accuri Cytometers announces completion of $6 million Series E preferred stock financing

Accuri Cytometers, Inc., a world leader in providing life science researchers with easy-to-use, cost-effective flow cytometers, today announced completion of a $6 million Series E preferred stock financing. The financing included current investors Arboretum Ventures, Baird Venture Partners, Fidelity Biosciences, Flagship Ventures and the InvestMichigan! Program co-managed by Credit Suisse.

12 Jul 2010

Bedford Laboratories launches Dactinomycin for Injection

Bedford Laboratories™, a division of Ben Venue Laboratories, Inc., is pleased to announce the addition of Dactinomycin for Injection USP 500 mcg (0.5 mg) to its comprehensive line of generic oncology products. Dactinomycin was approved earlier this year by the U.S. Food and Drug Administration (FDA) and is AP rated and equivalent to Cosmegen® by Lundbeck Inc. Each single dose vial contains 0.5 mg (500mcg) of dactinomycin and 20 mg of mannitol and is individually boxed.

12 Jul 2010

Today's OpEds: Churchillian Berwick?; Government's obesity fight; WSJ on paying for health reform

In an ideal world, Berwick would be Medicare's Winston Churchill, a prophetic voice who emerges from the wilderness and ends years of appeasement and denial. He tells the truth about federal health care and medicine generally. It's no wonder the Obama administration didn't think the Senate could handle it (Jay Hancock, 7/11).

12 Jul 2010

BSD receives FDA review questions for Phase II MTX-180 Microwave Ablation System 510(k) submission

BSD Medical Corporation today announced that it has received review questions from the U.S. Food and Drug Administration (FDA) regarding the 510(k) submission the Company filed for premarket clearance of the Company's Phase II MicroThermX® Microwave Ablation System (MTX-180) for ablation of soft tissue.

12 Jul 2010

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

GE Healthcare Medical Diagnostics today announced the market reintroduction of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms. Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders. The safety and efficacy of Optison with exercise stress or pharmacologic stress testing have not been established.

12 Jul 2010

Stanford University, OHSU receive grants to study VIAject for treating patients with diabetes

Biodel Inc. announced today the award of two research grants by the Juvenile Diabetes Research Foundation to Stanford University and Oregon Health & Science University to evaluate the use of VIAject (ultra-rapid-acting injectable human insulin) in the treatment of diabetes.

12 Jul 2010

Study results show cognitive decline significantly lower among regular tea drinkers

Results of a new study found people age 65 or older who drank tea regularly had 17-37% less cognitive decline compared with people who did not drink tea. The new findings were presented here at the Alzheimer's Association's International Conference on Alzheimer's Disease 2010.

12 Jul 2010

Food News and Research

Behavioral change programs help lower risk for cardiovascular diseases: Scientific statement

Food portion control is a matter of perception, suggests study

Watson Laboratories files ANDA with FDA for generic Renvela for oral suspension

Human Genome Sciences, Lonza announce commercial supply agreement for BENLYSTA

Fresh salsa and guacamole may be important vehicles of foodborne infection, says ORISE researcher

Exercise can reverse effects of early-life trauma

Tart cherry juice could help reduce severity of insomnia in older adults: Study

Portion control all a matter of perception!

News outlets examine Haitian rebuilding effort six months after major quake

Government report questions double use of CT scans at Illinois, Florida hospitals

Efficacy data of Caldolor Injection in treating fever associated with falciparum malaria published

BioSpecifics' partner Auxilium provides update on XIAFLEX

B. Braun Medical announces availability of large volume heparin infusion solutions

Accuri Cytometers announces completion of $6 million Series E preferred stock financing

Bedford Laboratories launches Dactinomycin for Injection

Today's OpEds: Churchillian Berwick?; Government's obesity fight; WSJ on paying for health reform

BSD receives FDA review questions for Phase II MTX-180 Microwave Ablation System 510(k) submission

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

Stanford University, OHSU receive grants to study VIAject for treating patients with diabetes

Study results show cognitive decline significantly lower among regular tea drinkers

The future is bioengineered: Synthetic biology and global sustainability eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News